Evidence map›Paper›PMID 42329168›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2026

Personalizing cancer care for older adults.

Jingran Ji, Mina S Sedrak

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Jingran JiDepartment of Medicine, Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, California, United States.ORCID 0000-0002-7284-0709
Mina S SedrakDepartment of Medicine, Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, California, United States.ORCID 0000-0002-8379-391X

Funding

Targeting Senescence to Mitigate Chemotherapy-induced Functional DeclineR01CA280088 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Mina S Sedrak · 2023 to 2026
$2.7M
Targeting Senescence to Improve Frailty in Older Cancer SurvivorsK76AG074918 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SEDRAK, MINA S · 2022 to 2024
$729k
Using Senolytics to Improve Physical Function in Older Breast Cancer SurvivorsR21CA277660 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SEDRAK, MINA S · 2023 to 2024
$422k
Mitigating Physical Function Decline in Older Adults with Gastroesophageal CancerR03AG095803 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JI, JINGRAN · 2025 to 2025
$394k
ASCO Career Development 2024CDA-8346891688Breast Cancer Research Foundation BCRF 25-228NCI NIH HHS R01 CA280088NCI NIH HHS R01CA280088NCI NIH HHS R21 CA277660NCI NIH HHS R21CA277660NIA NIH HHS K76 AG074918NIA NIH HHS K76AG074918NIA NIH HHS R03 AG095803NIA NIH HHS R03AG095803
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42329168
PMCPMC13284996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.